Smith & Nephew SNATS PE Ratio 2006-2018 | SNN

Current and historical p/e ratio for Smith & Nephew SNATS (SNN) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Smith & Nephew SNATS PE ratio as of April 19, 2019 is 0.00.
Smith & Nephew SNATS PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-04-18 37.99 inf
2018-12-31 37.38 0 0.00
2018-06-30 37.24 0 0.00
2017-12-31 34.33 0 0.00
2017-06-30 33.94 0 0.00
2016-12-31 28.95 $0.36 80.41
2015-12-31 33.62 $0.59 56.99
2015-06-30 31.85 $0.79 40.31
2014-12-31 34.10 $1.13 30.28
2014-09-30 31.04 $1.13 27.56
2014-06-30 32.91 $1.16 28.28
2014-03-31 27.87 $1.25 22.33
2013-12-31 26.14 $1.23 21.29
2013-09-30 22.56 $1.18 19.05
2013-06-30 20.27 $1.22 16.67
2013-03-31 20.57 $1.59 12.95
2012-12-31 19.74 $1.63 12.10
2012-09-30 19.45 $1.63 11.95
2012-06-30 17.64 $1.63 10.84
2012-03-31 17.64 $1.31 13.44
2011-12-31 16.82 $1.30 12.94
2011-09-30 15.50 $1.40 11.10
2011-06-30 18.78 $1.40 13.46
2011-03-31 19.40 $1.36 14.22
2010-12-31 18.07 $1.38 13.13
2010-09-30 15.51 $1.26 12.35
2010-06-30 16.06 $1.24 12.91
2010-03-31 16.96 $1.20 14.09
2009-12-31 17.37 $1.06 16.32
2009-09-30 15.16 $1.04 14.64
2009-06-30 12.55 $0.91 13.82
2009-03-31 10.40 $0.87 11.93
2008-12-31 10.75 $0.84 12.80
2008-09-30 17.57 $0.80 21.86
2008-06-30 18.12 $0.68 26.81
2008-03-31 21.72 $0.68 31.94
2007-12-31 18.90 $0.68 27.63
2007-09-30 20.08 $0.76 26.28
2007-06-30 20.34 $0.77 26.35
2007-03-31 20.71 $0.76 27.39
2006-12-31 17.07 $1.44 11.82
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.615B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71